Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review

Published:2019-10-17 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Tong Qiang,Zhu Peng-chong,Zhuang Zhuang,Deng Li-hui,Wang Zi-hao,Zeng Hua,Zheng Guo-qing,Wang Yan

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference110 articles.

1. Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models;Alex;PLOS Med.,2017

2. Caco-2 monolayers in experimental and theoretical predictions of drug transport;Artursson,2001

3. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity;Astashkina;Pharmacol. Ther.,2012

4. Current sample size conventions: flaws, harms, and alternatives;Bacchetti;BMC Med.,2010

5. Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool;Bao;Front. Pharmacol.,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WeiNaiAn capsule attenuates intestinal mucosal injury and regulates gut microbiome in indomethacin-induced rat;The International Journal of Biochemistry & Cell Biology;2024-08

2. The neuroprotective effect of Chinese herbal medicine for cerebral ischemia reperfusion injury through regulating mitophagy;Frontiers in Pharmacology;2024-06-04

3. Aflatoxin B1 inhibited the development of primary myoblasts of grass carp (Ctenopharyngodon idella) by degrading extracellular matrix;Ecotoxicology and Environmental Safety;2024-05

4. Notoginsenoside R1 attenuates brain injury in rats with traumatic brain injury: Possible mediation of apoptosis via ERK1/2 signaling pathway;PLOS ONE;2023-12-18

5. The characteristics and molecular targets of antiarrhythmic natural products;Biomedicine & Pharmacotherapy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3